Publications by authors named "Andreas Galanopoulos"

Claim this Profile
P
Preferences and perceptions of 617 migraine patients on acute and preventive migraine treatment attributes and clinical trial endpoints.
Michail Vikelis, Dimitrios Rikos, Andreas A Argyriou, Pinelopi Papachristou, Dimitrios Rallis, Andreas Galanopoulos

Expert Rev Neurother· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness of vortioxetine in outpatients with major depressive disorder: functioning and dose effects.
Eugenia Papalexi, Andreas Galanopoulos, Dimitrios Kontis, Maria Markopoulou, Georgia Balta

BMC Psychiatry· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cannabinoid CB1 receptor biphasically modulates motor activity and regulates dopamine and glutamate release region dependently.
Alexia Polissidis, Andreas Galanopoulos, George Naxakis, Demetris Papahatjis, Zeta Papadopoulou-Daifoti

Int J Neuropsychopharmacol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individual differences in the effects of cannabinoids on motor activity, dopaminergic activity and DARPP-32 phosphorylation in distinct regions of the brain.
Alexia Polissidis, Olga Chouliara, Andreas Galanopoulos, Georgia Rentesi, Maria Dosi

Int J Neuropsychopharmacol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Behavioural and dopaminergic alterations induced by a low dose of WIN 55,212-2 in a conditioned place preference procedure.
Alexia Polissidis, Olga Chouliara, Andreas Galanopoulos, Marios Marselos, Zeta Papadopoulou-Daifoti

Life Sci· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis